PhoenixBio Co., Ltd. (TYO:6190)
Japan flag Japan · Delayed Price · Currency is JPY
243.00
-6.00 (-2.41%)
Nov 18, 2026, 11:11 AM JST

PhoenixBio Revenue

PhoenixBio had revenue of 300.00M JPY in the quarter ending September 30, 2026, a decrease of -15.73%. This brings the company's total for the last twelve months to 1.37B, down -9.41% year-over-year. In the fiscal year ending March 31, 2026, PhoenixBio had annual revenue of 1.57B with 1.56% growth. That makes PhoenixBio the 38,063rd largest company in the world by revenue and 3,752nd in Japan.

Revenue (ttm)
1.37B
Revenue Growth
-9.41%
P/S Ratio
0.74
Revenue / Employee
24.85M
Employees
55
Market Cap
989.06M

Revenue Chart

Revenue by Geography

  • United States of America 853.06M 54.5%
  • Japan 423.63M 27.1%
  • Europe 193.88M 12.4%
  • Others 94.97M 6.1%
Fiscal year ended Mar 31, 2026 See the full PhoenixBio breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.57B24.00M1.56%
Mar 31, 20251.54B-174.00M-10.15%
Mar 31, 20241.72B-409.00M-19.26%
Mar 31, 20232.12B800.00M60.42%
Mar 31, 20221.32B311.00M30.70%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.